Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents

Shinkai, H; Onogi, S; Tanaka, M; Shibata, T; Iwao, M; Wakitani, K; Uchida, I

HERO ID

4923720

Reference Type

Journal Article

Year

1998

Language

English

PMID

9599241

HERO ID 4923720
In Press No
Year 1998
Title Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents
Authors Shinkai, H; Onogi, S; Tanaka, M; Shibata, T; Iwao, M; Wakitani, K; Uchida, I
Journal Journal of Medicinal Chemistry
Volume 41
Issue 11
Page Numbers 1927-1933
Abstract Isoxazolidine-3,5-dione 2 (JTT-501), one of the cyclic malonic acid derivatives, was found to decrease blood glucose at an oral dose of 38 mg/kg/day in KKAy mice and is currently undergoing evaluation in phase II clinical trials. Further studies on a series of malonic acids and related compounds showed that the 1,3-dicarbonyl structure was important for insulin-sensitizing activity. Dimethyl malonate 10, which was selected as a successor for 2, was the optimum compound in a series of 1,3-dicarbonyl compounds and was more potent than the corresponding thiazolidine-2,4-dione 1.
Doi 10.1021/jm970771m
Pmid 9599241
Wosid WOS:000073886300018
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English